Scott E. Kern
Impact in
- Oncology top 0.02%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 112
- Pancreatic and Hepatic Oncology Research 83
- Cancer-related Molecular Pathways 19
-
- Epigenetics and DNA Methylation 25
- DNA Repair Mechanisms 14
- TGF-β signaling in diseases 14
- Co-authors
- Bert Vogelstein (15 shared papers)Ralph H. Hruban (81 shared papers)Kenneth W. Kinzler (12 shared papers)Stanley R. Hamilton (5 shared papers)Eric R. Fearon (5 shared papers)Charles J. Yeo (42 shared papers)Mark Leppert (1 shared paper)Alida M.M. Smits (1 shared paper)
- Journals
- Cancer Biology & Therapy (22 papers)American Journal Of Pathology (14 papers)Cancer Research (11 papers)Genes Chromosomes and Cancer (11 papers)Science (7 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Scott E. Kern
174 papers receiving 31.0k citations
Scott E. Kern's Hit Papers
Peers
Comparison fields: 5 of 176
- Oncology 19.0k
- Cancer Research 8.5k
- Pathology and Forensic Medicine 7.9k
- Molecular Biology 16.5k
- Biotechnology 1.5k
Countries citing papers authored by Scott E. Kern
This map shows the geographic impact of Scott E. Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Kern more than expected).
Fields of papers citing papers by Scott E. Kern
This network shows the impact of papers produced by Scott E. Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Kern. The network helps show where Scott E. Kern may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott E. Kern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genetic Alterations during Colorectal-Tumor Development Hit paper breakdown → | 1988 | 5205 |
| 2 | DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 Hit paper breakdown → | 1996 | 1908 |
| 3 | Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis Hit paper breakdown → | 2011 | 1756 |
| 4 | Definition of a consensus binding site for p53 Hit paper breakdown → | 1992 | 1700 |
| 5 | Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers Hit paper breakdown → | 1990 | 1410 |
| 6 | Allelotype of Colorectal Carcinomas Hit paper breakdown → | 1989 | 1066 |
| 7 | Gene Expression Profiles in Normal and Cancer Cells Hit paper breakdown → | 1997 | 1007 |
| 8 | Identification of p53 as a Sequence-Specific DNA-Binding Protein Hit paper breakdown → | 1991 | 935 |
| 9 | Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Hit paper breakdown → | 1994 | 912 |
| 10 | Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators Hit paper breakdown → | 1998 | 849 |
| 11 | Pancreatic Intraepithelial Neoplasia Hit paper breakdown → | 2001 | 842 |
| 12 | DPC4 gene in various tumor types. Hit paper breakdown → | 1996 | 570 |
| 13 | Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene Hit paper breakdown → | 2009 | 565 |
| 14 | Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers Hit paper breakdown → | 1996 | 501 |
| 15 | 2004 | 479 | |
| 16 | Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). | 2001 | 473 |
| 17 | 2003 | 394 | |
| 18 | Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. | 2003 | 344 |
| 19 | 1991 | 327 | |
| 20 | Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. | 2002 | 321 |
About Scott E. Kern
Scott E. Kern is a scholar working on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 174 papers that have together received 31.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (83 papers), Cancer Genomics and Diagnostics (49 papers), Genetic factors in colorectal cancer (37 papers), Epigenetics and DNA Methylation (25 papers), Cancer-related Molecular Pathways (19 papers), DNA Repair Mechanisms (14 papers), TGF-β signaling in diseases (14 papers) and BRCA gene mutations in cancer (14 papers). The work is most often cited by research in Oncology (19.0k citations), Cancer Research (8.5k citations), Pathology and Forensic Medicine (7.9k citations), Molecular Biology (16.5k citations) and Biotechnology (1.5k citations). Scott E. Kern has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Bert Vogelstein, Ralph H. Hruban, Kenneth W. Kinzler, Stanley R. Hamilton, Eric R. Fearon, Charles J. Yeo, Mark Leppert, Alida M.M. Smits, Johannes L. Bos and Michael Goggins. Their work appears in journals such as Cancer Biology & Therapy, American Journal Of Pathology, Cancer Research, Genes Chromosomes and Cancer and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.